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Abstract
Background: Research exploring Bipolar Disorder (BD) phenotypes and mitochondrial dysfunction, particularly in younger
subjects, has been insufficient to date. Previous studies have found abnormal cerebral pH levels in adults with BD, which
may be directly linked to abnormal mitochondrial activity. To date no such studies have been reported in children with BD.
Methods: Phosphorus Magnetic Resonance Spectroscopy (31P MRS) was used to determine pH, phopshocreatine (PCr) and
inorganic phosphate (Pi) levels in 8 subjects with BD and 8 healthy comparison subjects (HCS) ages 11 to 20 years old.
Results: There was no significant difference in pH between the patients and HCS. However, frontal pH values for patients
with BD increased with age, contrary to studies of HCS and the pH values in the frontal lobe correlated negatively with the
YMRS values. Global Pi was significantly lower in subjects with BD compared with HCS. There were no significant differences
in PCr between the groups. Global PCr-to-Pi ratio (PCr/Pi) was significantly higher in subjects with BD compared with HCS.
Conclusions: The change in Pi levels for the patients with BD coupled with the no difference in PCr levels, suggest an
altered mitochondrial phosphorylation. However, our findings require further investigation of the underlying mechanisms
with the notion that a mitochondrial dysfunction may manifest itself differently in children than that in adults.
Limitations: Further investigations with larger patient populations are necessary to draw further conclusions.
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Introduction
In recent years, it has been suggested that Bipolar Disorder (BD)
may be a disorder of mitochondrial dysfunction [1,2,3]. In 2004,
Konradi et al. reported abnormal regulation of nuclear genes
coding for mitochondrial proteins in BD [4]. Such a deficit in
coding for mitochondrial proteins would mainly affect the
respiratory chain, causing energy metabolism dysfunction and
cellular degeneration [5]. How a dysfunction in energy metabo-
lism manifests itself clinically depends on many parameters and
indeed different or even the same mitochondrial dysfunction may
have different clinical manifestations [5].
Phosphorous Magnetic Resonance Spectroscopy (31P MRS) is
a method that allows for the measurement of pH, high-energy
phosphates, and phospholipid metabolism in vivo. Kato and
colleagues, throughout the 1990s and early 2000s, published
a number of studies showing altered pH (measured using 31P
MRS) in adults with BD. In particular, they showed reduced pH in
euthymic patients with BD [6,7,8,9,10]. These studies, coupled
with other findings that showed increased lactate (measured using
proton (1H MRS) in BD [11], suggest reduced pH as
a consequence of increased lactate levels due to a shift away from
oxidative phosphorylation towards glycolysis [3]. This shift may be
a consequence of mitochondrial dysfunction. Reductions in brain
mitochondrial function may be manifested by decreased phos-
phocreatine (PCr) and increased inorganic phosphate (Pi),
measured using 31P MRS [12]. Through their work on skeletal
muscle energetics, Chance et al. have suggested that the PCr-to-Pi
ratio (PCr/Pi) may be a sensitive marker of mitochondrial
dysfunction [13].
To the best of our knowledge, there are no published studies
using 31P MRS to investigate pH in children and adolescents with
BD. We are unaware of any studies that have reported the PCr-to-
Pi ratio (or Pi) in BD. The first aim of this study was to replicate
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the Kato studies in children and adolescents with BD to investigate
pH levels and putative mitochondrial dysfunction. Kato et al.
noted that while pH was lower in euthymic patients with BD,
patients who were manic or depressed had higher pH levels
compared with healthy comparison subjects (HCS) or euthymic
patients [7,8]. Based on these studies, we hypothesized that pH
would be higher in manic, mixed, or depressed children and
adolescents with BD compared with HCS or euthymic subjects
with BD. In addition, higher pH levels would be associated with
levels of mania (measured using the YMRS) and depression
(measured using the CDRS) in the children with BD. The second
aim of this study was to investigate the PCr/Pi in BD. We
hypothesized that, consistent with a mitochondrial dysfunction,
PCr would be reduced, Pi increased, and PCr/Pi reduced in
children and adolescents with BD, compared with HCS.
Materials and Methods
Subjects
The Institutional Review Boards at both McLean Hospital and
the Cambridge Health Alliance approved this study. All subjects
were recruited through McLean Hospital (outpatient, partial and
inpatient programs) and online advertising. All of the children
(with one exception) were interviewed with the Schedule for
Affective Disorders and Schizophrenia for School-Age Children
(KSADS-PL) by a child psychiatrist. For the purpose of this study,
we differentiated between the episodes and the current mood state
at a given time point. The past episodes and the diagnoses of BD
in the children, adolescents and young adults, based on un-
modified Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV TR) criteria, were made following the clinical inter-
views. One patient was an inpatient at McLean Hospital at the
time of the study, this subject was not interviewed with the
KSADS-PL due to scheduling issues. This subject had a previous
diagnosis of BD made by a child psychiatrist. The current mood
state was determined in all of the subjects on the day of the
imaging using the Young Mania Rating Scale (YMRS: [14]) and
the Children’s Depression Rating Scale-Revised (CDRS: [15,16]).
(Manic: YMRS=12 or above; CDRS=29 or below. Depressed:
CDRS=30 or above; YMRS=11 or below. Mixed: YMRS=12
or above; CDRS=30 or above. Euthymic: YMRS=11 or below;
CDRS=29 or below). Exclusion criteria included: a history of
a uncontrolled general medical disorder; a history of neurological
illness (including head trauma with loss of consciousness, seizure
disorder, multiple sclerosis, cerebral ischemia or infarction,
neoplasia); autism; schizophrenia; alcohol or drug dependence
(during two months prior to scan or total past history of $12
months); mental retardation (full scale I.Q. ,70 (historical
measure)); electroconvulsive therapy; a contraindication to MR
scan including metal fragments or implants; claustrophobia;
lactation; pregnancy (all females of child bearing age passed
a negative pregnancy urine test prior to scanning). Unique
exclusion criteria for the healthy comparison subjects included
an Axis I diagnosis and a family history of a mood disorder in a first
degree relative. Family history of DSM-IV psychiatric diagnoses
was obtained during the phone screen and during the clinical
assessment and interview about the child from the parents.
After the study was described, all parents signed a written
informed consent form and all children signed a written informed
assent form. Adult study participants (18 years or older) signed
a written informed consent form.
MR Imaging and Spectroscopy
Magnetic Resonance Spectroscopy (MRS) studies were per-
formed on a 4.0 T Varian Unity/Inova whole body MR scanner
(Varian NMR Instruments, Palo Alto, CA) equipped with a dual-
tuned proton-phosphorus head coil (Bioengineering Inc., Minnea-
polis, MN). Sagittal T1-weighted, magnetization-prepared 3D-
FLASH (fast, low-angle shot) images were collected for chemical
shift imaging (CSI) slab placement. An optimized phosphorus 2D-
CSI, pulse-acquire sequence acquired 31P-CSI data from the mid-
sagittally-placed slab (matrix size = 868, TR=3 s; tip-angle = 80u;
slice thickness = 3 cm; Rx bandwidth =62 kHz; complex-
points = 1024; readout duration= 256 ms; NEX=k-space weight-
ed; pre-acquisition delay = 1.2 ms; field of view
(FOV) = 24 cm624 cm; nominal voxel volume= 27 ml, scan-
time= 23 min). Effective voxel-volume for 31P-CSI was defined
as the cylindrical volume bound by the FWHM of the point-
spread function (PSF) and estimated to be ,50 cc. For each scan,
a 5-by-4 voxel grid was centered within the brain according to
axial images that fell within the 3 cm thick slab. For the frontal
analysis, the grid was positioned such that 4 voxels encompassed
the entire frontal cortical region, just anterior to the genu of the
corpus callosum. The four frontal voxels were in-line from left to
right (see Figure 1).
Data Processing and Analysis
The 31P-CSI data were first read into a zero-padded 868
matrix (including the 564 sub-matrix containing the brain) and
corrected by a set of scalar correction factors that correct each k-
space sample for the discrepancy of defining an optimal,
theoretical k-space filter with an integer number of averages for
each phase-encode step. The corrected 31P-CSI data were then
Fourier-Transformed to spatially-resolve each voxel throughout
the brain. Each spatially-resolved spectrum was stored as a time-
domain free-induction decay (FID) for each voxel (see Figure 2).
Spectral Fitting
All 31P-CSI spectra were fitted individually on a voxel-by-voxel
basis with a non-linear, iterative routine developed on-site, based
on the Marquardt-Levenberg algorithm for non-linear, least-
squares fitting of complex waveforms. The routine incorporates
the use of prior spectral knowledge such as J-coupling constants,
chemical-shifts and linewidths and applies pre-optimized con-
straints to converge on an optimal fit. The template that we used
for 31P fitting at 4T models each metabolite as a series of
Lorentzian and Gaussian lineshapes. In our template we have
models that include phospocreatine (PCr), nucleoside triphosphate
(NTP), and inorganic phosphate (Pi) as Lorenztians and
phosphoethanolamine (PEth), phosphocholine (PCh), Phosphoser-
ine (PSer), gylcerophosphoethanolamine (GPEth), phosphocholine
(GPCh) and MP (membrane phospholipid) as Gaussians. For each
metabolite, the raw peak areas returned by the routine were
expressed as a ratio to total phosphorus, referring to the total
integrated area under the entire modeled spectrum. Whole-slab (5-
by-4 voxel grid) and frontal lobe 31P brain metabolite ratios
normalized to total 31P signal per voxel were then derived from the
31P data. Whole brain and frontal lobe pH levels were determined
by finding the chemical-shift difference between the inorganic-
phosphate (Pi) and phosphocreatine (PCr) resonances. In addition,
the metabolite values were averaged across all voxels to obtain the
global measurements and across the frontal lobe voxels to obtain
the frontal lobe measurements.
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Statistics
Statistical analysis was performed using SPSS 20 software
package. Due to the small sample size non-parametric tests were
used: the Mann-Whitney U Test to compare between groups
differences, and Spearman’s rho for examining correlations. A p-
value of 0.05 was considered significant.
Results
Sixteen subjects participated in this study: 8 subjects who meet
criteria for BD (age: 16.9461.99 years; 2 female) and 8 HCS (age
15.5363.42; 4 female). The subjects with BD had a mean YMRS
of 11.5669.02 and CDRS of 27.3866.21, compared with
0.5560.93 and 17.7360.90, for the HCS subjects, respectively.
Subject demographics are shown in Table 1. There was no
significant difference in age between the groups. Three of the
subjects with BD were euthymic, the remaining 5 were either
mixed, manic or depressed. The YMRS and CDRS were
significantly different between the groups: Mann-Whitney U test
p,0.001.
pH
pH was not significantly different between the two groups.
Global pH was 7.0060.02 in subjects with BD (N=8); and
7.0060.02 in HCS (N=8). Frontal lobe pH values were
6.9960.03 in subjects with BD (N=7) and 6.9960.03 in HCS
(N=7). There were no significant difference in pH between the
euthymic children with BD and the depressed/manic/mixed
mood children; or between the HCS and the depressed/manic/
mixed mood children. In the subjects with BD the YMRS
correlated negatively with pH in the frontal lobes (Spearman’s
rho=20.75, p = 0.05, N= 7) (see Figure 3A). There was no
correlation between the CDRS and pH in either region. In
addition, there was a positive correlation between the age and the
frontal pH levels only for patients (Spearman’s rho= 0.64,
p = 0.12, N=7) (see Figure 3B).
PCr-to-Pi Ratio (PCr/Pi)
The global PCr/Pi was significantly higher in subjects with BD
compared with HCS (Mann-Whitney U-test, p = 0.05). There was
a trend for frontal lobe PCr/Pi to be higher in subjects with BD
compared with HCS (p= 0.18). Global PCr/Pi was 2.8460.69 in
subjects with BD (N=8); and 2.3560.31 in HCS (N=8). Frontal
lobe PCr/Pi values were 2.8960.91 in subjects with BD (N=7)
and 2.4060.54 in HCS (N=7).
There were no significant difference in PCr/Pi between the
euythmic children with BD and the depressed/manic/mixed
mood children. However the depressed/manic/mixed mood
children retained the higher global PCr/Pi compared with HCS
(p= 0.08).
For the subjects with BD there was no correlation between
YMRS and CDRS and either region’s PCr/Pi.
Pi
Global Pi was significantly lower in patients with BD compared
with HCS: 0.06660.005 in BD (N=8) and 0.07660.009 in HCS
(N=8) (Mann-Whitney U-test, p = 0.021). In addition, global Pi
was significantly lower in depressed/manic/mixed mood children
(0.06560.006, N= 5, p = 0.028) compared with HCS. Analysis of
frontal lobe Pi values showed no significant difference between any
of the experimental groups.
PCr
There was no significant difference in global or frontal lobe PCr
values between either of the experimental groups.
Discussion
Contrary to our hypothesis, there was no significant difference
in pH between the two groups. In a 31P MRS study, Rae et al.
demonstrated that pH decreases in the frontal lobes of healthy
subjects with age (98 males, ages 6 to 72 years old) [17]. However,
our findings show that even though we only have data from 8
patients, the pH ranges from 6.96 to 7.04 in the frontal lobes of the
BD patients, which is an increase of 1.14%. Therefore, despite
there being no significant difference in pH between the groups, pH
values in BD patients increased with age rather than the expected
decrease. This is perhaps related to the fact that the younger
subjects with BD in the study having the higher YMRS values:
because contrary to our hypothesis lower pH was associated with
higher YMRS values.
Figure 1. Slice location (top) where global chemical shift
imaging grid (564 grid) and frontal lobe grid (164 grid) were
located.
doi:10.1371/journal.pone.0054536.g001
Bioenergetics in Children with Bipolar Disorder
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e54536
These 31P MRS results are in agreement with our previous 1H
MRS study demonstrating reduced glutamine (Gln) in the anterior
cingulate cortex (ACC) of non-medicated children with BD (all of
whom were mixed: manic and depressed) compared with HCS
[18]. The brain metabolism of glutamate and glutamine is pH
sensitive. Alkalinization of astrocytes results in increased uptake of
glutamate and glutamine synthesis [19]. This result is consistent
with the result here - higher YMRS values being associated with
lower pH and lower pH associated with lower glutamine synthesis.
We did not observe any significant differences in PCr, however
global Pi was lower for patients with BD, and PCr/Pi was higher
for the patients compared with the healthy subjects. This finding
was contrary to our second hypothesis and the expected result of
reduced PCr accompanied by an increase in Pi levels.
A possible explanation for the lower Pi values for the BD
patients may be the fact that 6 out of the 8 patients were on
lithium treatment, while 3 of the patients with BD tested positive
for Tetrahyrdocannabinal (THC). Lithium has been also shown to
reduce Pi in healthy subjects treated with lithium over a 14-day
period (measured using 31P MRS [20]). In addition, THC has
been shown to increase glial Ca2+ [21], which may lead to reduced
Pi levels [19]. Therefore the results seen here for Pi may be
a consequence of lithium and/or THC intake.
Nevertheless, the change in Pi levels coupled with the no
difference in PCr levels, as observed in the patients with BD,
suggests an altered mitochondrial phosphorylation [22,23].
As stated in the introduction, how a dysfunction in energy
metabolism manifests itself clinically depends on many parameters
and indeed different, or even the same mitochondrial dysfunction
may have different clinical manifestations [5].
Conclusions
In this study, we aimed to investigate the patients with BD using
31P MRS, to understand the possible underlying mitochondrial
dysfunctions for children and adolescents with BD.
Our results showed no significant difference in pH levels
between the patients and HCS. However, pH levels acquired from
the frontal lobes of BD patients increased with age, contrary to
studies in HCS. Moreover, in the subjects with BD the YMRS
correlated negatively with pH in the frontal lobes. Global Pi was
significantly lower in patients with BD compared with HCS. Since
we did not observe any significant difference in PCr between the
groups, global PCr/Pi was significantly higher in patients with BD
compared with HCS. The change in Pi levels for the patients with
BD coupled with the no difference in PCr levels, suggest an altered
mitochondrial phosphorylation.
Limitations and Future Directions
The inclusion of only 16 subjects gave the study a limited
capability to represent a realistic population of healthy subjects
and subjects with Bipolar Disorder. In addition, even though all
patients had a confirmed diagnosis of Bipolar Disorder, the patient
Figure 2. 31P MR spectrum from a whole (global) brain slice. A) Residual of fit; B) 31P MR spectrum; C) Spectral Fit.
doi:10.1371/journal.pone.0054536.g002
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group consisted of depressed/manic/mixed mood children as well
as three euthymic children. One subject did not have a KSADS-
PL interview at the time of the study (but had a diagnosis of BD)
and they were unwilling to return for the evaluation. An analysis
conducted excluding this subject did not alter the significant results
of the study. In addition, all but two subjects were medicated with
lithium, and three subjects tested positive for THC including the
one non-medicated subjects with BD; this may have a confounding
effect on the results. Given the small sample size we were unable to
conduct a data analysis excluding these subjects. Finally, tissue
differences, i.e. white vs. gray matter vs. CSF content, may
possibly be a confounding variable, which needs to be further
studied using a high resolution anatomical images. However, due
to the global nature of the analysis, we would not expect to see any
difference between the patients and healthy comparison subjects.
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Table 1. Demographic information for subjects who participated in this study.
Subject Sex
Age
(at scan)
Height
(cm)
Weight
(kg) Race Diagnosis
Comorbid
Diagnosis
Lithium
(Li)
Li Rx
(mg)
Other
Medications YMRS CDRS
HCS 1 M 11.4 160 40.8 Caucasian HCS none – – – 3 17
HCS 2 M 12.0 162.6 39.9 Caucasian HCS none – – – 0 17
HCS 3 M 12.3 137.2 37.2 Caucasian HCS none – – – 1 18
HCS 4 F 15.7 152.4 46.3 African-American HCS ADHD – – – 0 17
HCS 5 F 16.0 154.9 51.7 Caucasian HCS none – – – 0 17
HCS 6 F 16.8 167.6 61.2 Caucasian HCS none – – – 0 18
HCS 7 M 19.8 190.5 79.3 Caucasian HCS none – – – 0 19
HCS 8 F 20.2 160.2 59 African-American HCS none – – – 1 19
BD 1 M 14.5 152.4 38.6 African-American BD N/A Yes N/A 3,4 24 37
BD 2 M 14.7 170.2 63.5 Caucasian BD OCD Yes 900 1,2,9 17 25
BD 3 M 15.7 180.3 82.6 Caucasian BD ADHD,PTSD Yes 1000 10,11,12,6,13 4 19
BD 4 M 17.0 172.7 62.6 Caucasian BD ADHD,OCD,ODD Yes 520 5,6,2,4 6 31
**BD 5 M 17.3 177.8 63.5 African-American BD ADHD Yes 450 7,8 1 20
BD 6 F 20.4 162.6 58.1 Caucasian BD PTSD,Bulimia Yes 900 5 5 26
**BD 7 M 17.2 175.3 84.8 African-American BD N/A No 0 8 12 33
**BD 8 F 18.7 167.6 70.3 Caucasian BD none No 0 15,2 23.5 28
(KEY: Other Medications: 1 = risperidone, 2 = lamotrogine, 3 = atomoxetine, 4 = quetipine, 5 = valproate, 6 = dexmethylphenidate, 7 = clonodine, 8 =methylphenidate,
9 = bupropion, 10 =benzatropine, 11 = paliperidone, 12 = desipramine, 13 = clonazepam, 14 = fluvoxamine, 15 = citalopram; **=drug test positive for THC).
HCS: Healthy comparison subject. BD: Subjects with Bipolar Disorder. ADHD: Attention Deficit Hyperactivity Disorder. ODD: Oppositional Defiant Disorder. OCD:
Obsessive–Compulsive Disorder. PTSD: Post-Traumatic Stress Disorder. For other abbreviations see text.
doi:10.1371/journal.pone.0054536.t001
Figure 3. Scatter plot of frontal pH levels A) against the Young Mania Rating Scale (YMRS), B) against the ages for the Bipolar
Disorder patients (n=7).
doi:10.1371/journal.pone.0054536.g003
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